Envestnet Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $686K | Buy |
|
|||||
|
2024
Q4 | $1.04M | Sell |
|
|||||
|
2024
Q3 | $2.34M | Buy |
|
|||||
|
2024
Q2 | $1.9M | Buy |
|
|||||
|
2024
Q1 | $1.45M | Sell |
|
|||||
|
2023
Q4 | $4.19M | Sell |
|
|||||
|
2023
Q3 | $3.55M | Buy |
|
|||||
|
2023
Q2 | $2.84M | Buy |
|
|||||
|
2023
Q1 | $2.72M | Sell |
|
|||||
|
2022
Q4 | $2.09M | Sell |
|
|||||
|
2022
Q3 | $2.94M | Buy |
|
|||||
|
2022
Q2 | $2.6M | Buy |
|
|||||
|
2022
Q1 | $3.52M | Buy |
|
|||||
|
2021
Q4 | $3.61M | Buy |
|
|||||
|
2021
Q3 | $3.98M | Buy |
|
|||||
|
2021
Q2 | $3.4M | Sell |
|
|||||
|
2021
Q1 | $3.5M | Buy |
|
|||||
|
2020
Q4 | $1.85M | Buy |
|
|||||
|
2020
Q3 | $1.06M | Buy |
|
|||||
|
2020
Q2 | $891K | Buy |
|
|||||
|
2020
Q1 | $817K | Buy |
|
|||||
|
2019
Q4 | $581K | Buy |
|
|||||
|
2019
Q3 | $582K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $29K | Sell |
|
|||||
|
2016
Q4 | $28K | Buy |
|
|||||
|
2016
Q3 | $23K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $40K | Sell |
|
|||||
|
2015
Q4 | $70K | Sell |
|
|||||
|
2015
Q3 | $104K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $68K | Sell |
|
|||||
|
2014
Q3 | $95K | Sell |
|
|||||
|
2014
Q2 | $761K | Sell |
|
|||||
|
2014
Q1 | $690K | Sell |
|
|||||
|
2013
Q4 | $912K | Buy |
|
|||||
|
2013
Q3 | $686K | Buy |
|
|||||
|
2013
Q2 | $766K | Buy |
|